Although there is evidence that the Rho/Rho kinase pathway and protein kinase C (PKC) are involved in the development of cerebral vasospasm, the mechanism by which subarachnoid hemorrhage (SAH) activates these pathways is unclear. A large body of evidence points to oxyhemoglobin (OxyHb) as a major causative component of blood clot responsible for vasospasm. Therefore, the present studies were conducted to explore whether the Rho/Rho kinase and PKC may be involved in a sustained vasoconstriction induced by OxyHb in cerebral arteries. OxyHb evoked sustained vasoconstriction in the endothelium-denuded rabbit basilar arteries, which was reversed by the selective inhibitors of Rho kinase, Y-27632, and HA-1077, with the IC50 values of 0.26+/-0.02 and 0.74+/-0.1 micromol/L, respectively. In quiescent cerebrovascular smooth muscle (CVSM) cells, OxyHb induced Rho translocation, as assessed by immunoblotting, with a time course, which paralleled the contractile action of OxyHb. Rho translocation was also observed in intact arteries stimulated with OxyHb for 24 hours (219%) and 48 hours (160%). The increase in Rho translocation was fully inhibited by GGTI-297, an inhibitor of Rho prenylation. OxyHb also caused significant translocation of both PKCalpha and PKCepsilon (P<0.01), which was maximal at the time corresponding to maximal tension developed in response to OxyHb. Ro-32-0432, an inhibitor of PKC, attenuated vasoconstriction mediated by OxyHb in basilar artery. These results show, for the first time, that OxyHb-mediated signaling in CVSM utilizes the Rho/Rho kinase and PKC-based mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.RES.0000066663.12256.B2DOI Listing

Publication Analysis

Top Keywords

rho/rho kinase
12
rho translocation
12
kinase pathway
8
pathway protein
8
protein kinase
8
subarachnoid hemorrhage
8
kinase pkc
8
pkc involved
8
sustained vasoconstriction
8
oxyhb
7

Similar Publications

Objective: Gliomas are a general designation for neuroepithelial tumors derived from the glial cells of the central nervous system. According to the histopathological and immunohistochemical features, the World Health Organization classifies gliomas into four grades. Bevacizumab is a monoclonal antibody targeting vascular endothelial growth factor that has been approved for the treatment of glioblastoma multiforme (GBM) as a second-line therapy.

View Article and Find Full Text PDF

Objective: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that emerges in early childhood and is characterized by difficulties in social communication, repetitive behaviors, and restricted interests. The Ras homolog (Rho)/Rho-kinase signaling pathway plays a critical role in maintaining synaptic structure and function, as it regulates the actin cytoskeleton. This study aims to investigate the expression of the Ras homolog (Rho) family member A (), Rho-kinase 1 (), and Rho-kinase 2 () genes within this pathway in relation to ASD.

View Article and Find Full Text PDF

Tramadol and duloxetine, reuptake inhibitors of serotonin and noradrenaline, are widely used analgesics. Cytoplasmic serotonin in human platelets reportedly regulates the activity of low-molecular-weight GTP-binding proteins via serotonylation, leading to the modulation of platelet functions. We recently showed that the combination of thrombopoietin and collagen in the low doses synergistically induces human platelet activation via Rac and Rho/Rho-kinase.

View Article and Find Full Text PDF
Article Synopsis
  • * Research indicates that the rhoA/rho-kinase pathway, which is activated by gentamicin, contributes to kidney damage similar to that seen in diabetes and renal ischemia.
  • * The study shows that administering the antioxidant alpha-linolenic acid (ALA) alongside gentamicin to mice reduced the damaging effects on the Rho/Rho-kinase pathway, suggesting that oxidative stress plays a key role in gentamicin-induced nephrotoxicity.
View Article and Find Full Text PDF
Article Synopsis
  • High-risk neuroblastoma has a dismal outlook, underscoring the need for innovative treatment strategies, particularly targeting Rho GTPase signaling which has been linked to both the disease and resistance to therapies.
  • The dual ROCK inhibitor RKI-1447 showed significant anti-cancer effects by reducing tumor growth, boosting cell death, and inhibiting key oncogenes like N-MYC in both lab and animal studies.
  • Combining RKI-1447 with BET inhibitors like ABBV-075 enhanced treatment effects and helped in overcoming resistance, presenting a potential strategy to improve neuroblastoma therapies while minimizing side effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!